A March 2025 study in Cell Reports Medicine finds that muscle loss from GLP-1 drugs mirrors ordinary weight loss, alleviating public concern. A new study reassures that GLP-1 drugs do not cause dispro...
Recent UK Biobank data reveals myostatin variants boosting muscle mass, with research accelerating on combining inhibitors with GLP-1 drugs to combat sarcopenia, highlighting ethical debates in therap...
